Baojin Hua

1.8k citations
38 papers · 1.3k indexed · h-index 19

Baojin Hua

37 papers receiving 1.3k citations

Peers

Baojin Hua
Comparison fields: 5 of 100
  • Cancer Research 266
  • Pharmacology 124
  • Oncology 327
  • Complementary and alternative medicine 93
  • Molecular Biology 641
Replace Jiasheng Mu with:
Jiasheng Mu China
Hui Cao China
Dae‐Woon Eom South Korea
Junhua Zheng China
Lizhu Lin China
Wanyin Wu China
Mei Meng China
Shakir M. Saud United States
Animesh Dhar United States
Yueh-Min Lin Taiwan
Baojin Hua relative to Jiasheng Mu China Jiasheng Mu's profile →
Citations per field
00.5×2.7×
Jiasheng Mu · 1×
Citations per year

Countries citing papers authored by Baojin Hua

Since Specialization
Citations

This map shows the geographic impact of Baojin Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baojin Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baojin Hua more than expected).

Fields of papers citing papers by Baojin Hua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baojin Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baojin Hua. The network helps show where Baojin Hua may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Baojin Hua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Baojin Hua Line = papers co-authored together Baojin Hua links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20243
3 20223
4 202120
5 20214
6 202018
7 20198
8 201934
9 201820
10 2018221
11 20176
12 201730
13 201740
14 201630
15 201545
16 201483
17
Discussion on Problems of Serum Pharmacological Experiment of Chinese Medicine
20131
18
Clinical Observation of Network Vessel-Freeing Formula as a Topical Wash Combined for 34 Cases of Chemotherapy-Induced Peripheral Neuropathy
20121
19 201138
20 200818

About Baojin Hua

Baojin Hua is a scholar working on Pharmacology, Cancer Research and Complementary and alternative medicine, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (5 papers), Cancer-related molecular mechanisms research (4 papers), Gastric Cancer Management and Outcomes (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Immune cells in cancer (4 papers), Ginseng Biological Effects and Applications (3 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Cancer Research (266 citations), Pharmacology (124 citations) and Oncology (327 citations). Baojin Hua has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shakir M. Saud, Weidong Li, Guohong Chen, Rui Liu, Matthew R. Young, Qiujun Guo, Honggang Zheng, Yuan Yuan, Wei Hou and Shuntai Chen. Their work appears in journals such as Gastroenterology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026